Prahlad Ho

923 total citations
53 papers, 464 citations indexed

About

Prahlad Ho is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Prahlad Ho has authored 53 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Internal Medicine, 26 papers in Cardiology and Cardiovascular Medicine and 21 papers in Hematology. Recurrent topics in Prahlad Ho's work include Venous Thromboembolism Diagnosis and Management (30 papers), Atrial Fibrillation Management and Outcomes (19 papers) and Blood Coagulation and Thrombosis Mechanisms (17 papers). Prahlad Ho is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (30 papers), Atrial Fibrillation Management and Outcomes (19 papers) and Blood Coagulation and Thrombosis Mechanisms (17 papers). Prahlad Ho collaborates with scholars based in Australia, Singapore and United States. Prahlad Ho's co-authors include Hui Yin Lim, Harshal Nandurkar, Geoffrey A. Donnan, Mark Tacey, Cindy J. O’Malley, Chong Chyn Chua, Kay Weng Choy, Carole Smith, Andrew Grigg and David C. Reutens and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Prahlad Ho

49 papers receiving 458 citations

Peers

Prahlad Ho

CCM

HEMAT

EPIDE

SURGE

Evdoxia Gounari Greece

Galit Sarig Israel

Peter Baker United States

Jan-Håkan Jansson Sweden

Weijuan Li China

Marion Pépin France

Mehmet Zihni Bilik Türkiye

Anne Raby Canada

Michel Meyer Samama France

Yahya İslamoğlu Türkiye

Evdoxia Gounari Greece

Prahlad Ho

67 ×0.4

96 ×0.6

CCM

48 ×0.3

HEMAT

60 ×1.0

EPIDE

56 ×1.0

SURGE

Citations per year, relative to Prahlad Ho Prahlad Ho (= 1×) peers Evdoxia Gounari

Countries citing papers authored by Prahlad Ho

Since Specialization

Citations

This map shows the geographic impact of Prahlad Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prahlad Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prahlad Ho more than expected).

Fields of papers citing papers by Prahlad Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prahlad Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prahlad Ho. The network helps show where Prahlad Ho may publish in the future.

Co-authorship network of co-authors of Prahlad Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Prahlad Ho. A scholar is included among the top collaborators of Prahlad Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prahlad Ho. Prahlad Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nandurkar, Harshal, et al.. (2025). Tissue factor pathway inhibitor levels and atherothrombotic events in patients with chronic kidney disease or diabetes. Journal of Thrombosis and Thrombolysis. 58(3). 391–400. 1 indexed citations

Taylor, Sarah, Ray Boyapati, Bei Ye, et al.. (2025). Blood Group B May Reduce Risk of Rebleeding in Patients With Upper Gastrointestinal Haemorrhage due to Peptic Ulcer Disease. Alimentary Pharmacology & Therapeutics. 61(4). 706–711. 1 indexed citations

Leung, P. C., et al.. (2024). A 12-Year Review of Upper Extremity Deep Vein Thrombosis—Are They the Same as Lower Extremity Deep Vein Thrombosis?. Journal of Clinical Medicine. 13(21). 6440–6440. 1 indexed citations

Ho, Prahlad, et al.. (2024). Overall haemostatic potential assay for prediction of outcomes in venous and arterial thrombosis and thrombo-inflammatory diseases. Journal of Thrombosis and Thrombolysis. 57(5). 852–864.

Edwards, Kathryn M., Donald Campbell, Kanta Subbarao, et al.. (2024). Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I. Journal of Virological Methods. 327. 114944–114944. 1 indexed citations

Ho, Prahlad, et al.. (2024). A ten-year comparison of treatment and outcomes of cancer-associated thrombosis to non-cancer venous thromboembolism: from traditional anticoagulants to direct oral anticoagulants. Journal of Thrombosis and Thrombolysis. 57(4). 658–667.

Ho, Prahlad, et al.. (2023). A systematic review of venous thromboembolism mechanical prophylaxis devices during surgery. Langenbeck s Archives of Surgery. 408(1). 410–410. 10 indexed citations

Lim, Hui Yin, Mark Tacey, David Barit, et al.. (2023). Global coagulation assays in patients with chronic kidney disease and their role in predicting thrombotic risk. Thrombosis Research. 226. 127–135. 9 indexed citations

Lim, Hui Yin, et al.. (2023). DOAC‐stop can remove direct oral anticoagulants and allow analysis by global coagulation assays. International Journal of Laboratory Hematology. 45(3). 360–367. 2 indexed citations

10.

Choy, Kay Weng, et al.. (2022). Laboratory markers of severity across three COVID-19 outbreaks in Australia: has Omicron and vaccinations changed disease presentation?. Internal and Emergency Medicine. 18(1). 43–52. 13 indexed citations

11.

Ho, Prahlad, et al.. (2022). Management of venous thromboembolism in morbidly obese patients: a 10-year review. Journal of Thrombosis and Thrombolysis. 55(2). 304–311. 4 indexed citations

12.

Lim, Hui Yin, Geoffrey A. Donnan, Harshal Nandurkar, & Prahlad Ho. (2022). Global coagulation assays in hypercoagulable states. Journal of Thrombosis and Thrombolysis. 54(1). 132–144. 17 indexed citations

13.

Ho, Prahlad, et al.. (2022). A ten-year review of the impact of the transition from warfarin to direct oral anticoagulant – Has venous thromboembolism treatment become safer?. Thrombosis Research. 219. 112–120. 5 indexed citations

14.

Lim, Hui Yin, et al.. (2021). Global coagulation assays in patients with diabetes mellitus. Research and Practice in Thrombosis and Haemostasis. 5(7). e12611–e12611. 14 indexed citations

15.

Lim, Hui Yin, et al.. (2020). Assessing maternal clotting function with novel global coagulation assays: A prospective pilot study. International Journal of Laboratory Hematology. 43(3). 458–467. 5 indexed citations

16.

Lim, Hui Yin, Cindy J. O’Malley, Geoffrey A. Donnan, Harshal Nandurkar, & Prahlad Ho. (2019). A review of global coagulation assays — Is there a role in thrombosis risk prediction?. Thrombosis Research. 179. 45–55. 49 indexed citations

17.

Lim, Hui Yin, et al.. (2018). An evaluation of global coagulation assays in myeloproliferative neoplasm. Blood Coagulation & Fibrinolysis. 29(3). 300–306. 13 indexed citations

18.

Nandurkar, Harshal, et al.. (2017). Thrombin generation estimates the anticoagulation effect of direct oral anticoagulants with significant interindividual variability observed. Blood Coagulation & Fibrinolysis. 29(2). 148–154. 26 indexed citations

19.

Lim, Hui Yin, et al.. (2016). Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events. Journal of Thrombosis and Thrombolysis. 42(3). 423–431. 10 indexed citations

20.

Ho, Prahlad, et al.. (2012). Intermittent granulocyte colony‐stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia. European Journal Of Haematology. 88(5). 416–421. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact